サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1660915

調剤薬局の世界市場：業界分析、規模、シェア、成長、動向、予測（2025年～2032年）

Compounding Pharmacies Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025 - 2032

出版日
ページ情報
英文 245 Pages
納期
2～5営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
調剤薬局の世界市場：業界分析、規模、シェア、成長、動向、予測（2025年～2032年）
出版日: 2025年02月20日
発行: Persistence Market Research
ページ情報: 英文 245 Pages
納期: 2～5営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

世界の調剤薬局の市場規模は、2025年に114億米ドルになるとみられ、2025年～2032年の予測期間に5.2%のCAGRで拡大し、2032年には163億米ドルに達すると予測されています。

調剤薬局は、患者の特定のニーズに合わせてカスタマイズされた薬剤を作成することを専門とし、代替剤形、アレルゲンフリーの薬剤、または市販されていない薬剤の組み合わせを必要とする個人のためのソリューションを提供します。これらの薬局は、病院、専門クリニック、長期介護施設、個人患者に対応し、外用クリーム、注射剤、経口液剤、小児用剤などの配合剤を提供しています。市場成長の原動力は、個別化医療に対する需要の高まり、医薬品不足の深刻化、特殊な治療を必要とする慢性疾患の蔓延です。

世界の調剤薬局市場は、患者固有のニーズに対応するための個別化医療への嗜好の高まりなど、いくつかの重要な要因によって推進されています。がん、心血管疾患、ホルモンバランスの乱れなどの慢性疾患の罹患率の上昇により、オーダーメイド薬への需要が高まっています。さらに、老年人口の増加により、投与が容易な代替製剤が必要とされています。調剤薬局に対する規制上の支援や、無菌調剤や薬剤配合の自動化といった薬剤配合技術の進歩が、市場の拡大をさらに後押ししています。また、特定の必須医薬品が不足していることから、特に病院や専門医療現場において、配合薬への依存度が高まっています。

調剤薬局市場は、ヘルスケア支出の増加、調剤技術の進歩、オーダーメイド薬に対する意識の高まりなどを背景に、大きな成長機会をもたらしています。在宅ヘルスケアサービスや遠隔医療プラットフォームの拡大により、患者は調合薬を便利に利用できるようになっています。さらに、3D薬剤印刷、ナノテクノロジーに基づく製剤、投薬のカスタマイズにおける人工知能の統合など、調剤技術の革新は市場参入企業に新たな道を開いています。調剤薬局とヘルスケアプロバイダーとの戦略的パートナーシップは、研究開発への投資とともに、新たな機会を活用し、この進化する業界で市場のリーダーシップを維持する上で極めて重要です。

当レポートでは、世界の調剤薬局市場について調査し、製品別、用途別、治療分野別、地域別動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 エグゼクティブサマリー

第2章 市場概要

第3章 主要な市場動向

第4章 重要成功要因

第5章 市場背景

  • マクロ経済要因
  • 予測要因- 関連性と影響
  • 市場力学

第6章 COVID-19危機分析

第7章 世界の調剤薬局市場の需要（規模、10億米ドル）分析、2019年～2032年

  • 過去の市場金額（10億米ドル）分析、2019年～2024年
  • 現在および将来の市場金額（10億米ドル）予測、2025年～2032年

第8章 世界の調剤薬局市場分析、2019年～2032年、製品別

  • 過去の市場規模（価値または規模、10億米ドル）動向、製品別、2019年～2024年
  • 現在および将来の市場規模（価値または規模、10億米ドル）分析と予測、製品別、2025年～2032年
  • 製品別市場の魅力分析

第9章 世界の調剤薬局市場分析、2019年～2032年、用途別

  • 過去の市場規模（価値または規模、10億米ドル）動向、用途別、2019年～2024年
  • 現在および将来の市場規模（価値または規模、10億米ドル）分析と予測、用途別、2025年～2032年
  • 用途別市場の魅力分析

第10章 世界の調剤薬局市場分析、2019年～2032年、治療分野別

  • 過去の市場規模（価値または規模、10億米ドル）動向、治療分野別、2019年～2024年
  • 現在および将来の市場規模（価値または規模、10億米ドル）分析と予測、治療分野別、2025年～2032年
  • 治療領域別市場の魅力分析

第11章 世界の調剤薬局市場分析、2019年～2032年、地域別

  • 過去の市場規模（価値または規模、10億米ドル）動向、地域別、2019年～2024年
  • 現在および将来の市場規模（価値または規模、10億米ドル）分析と予測、地域別、2025年～2032年
  • 地域別市場の魅力分析

第12章 北米の調剤薬局市場分析、2019年～2032年

第13章 ラテンアメリカの調剤薬局市場2019年～2032年

第14章 欧州の調剤薬局市場分析、2019年～2032年

第15章 南アジアの調剤薬局市場分析、2019年～2032年

第16章 東アジアの調剤薬局市場分析、2019年～2032年

第17章 オセアニアの調剤薬局市場分析、2019年～2032年

第18章 中東・アフリカの調剤薬局市場分析、2019年～2032年

第19章 市場構造分析

  • 企業階層別市場分析
  • 市場集中
  • 主要企業の市場シェア分析
  • 市場プレゼンス分析

第20章 競合分析

  • 競合ダッシュボード
  • 競合の詳細
    • Fagron
    • Fresenius Kabi AG
    • PharMEDium Services, LLC,
    • Institutional Pharmacy Solutions
    • Cantrell Drug Company
    • Lorraine's Pharmacy
    • B. Braun Melsungen AG Company

第21章 使用される仮定と頭字語

第22章 調査手法

目次
Product Code: PMRREP5270

Persistence Market Research has recently released a comprehensive report on the worldwide market for compounding pharmacies. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure. This research publication presents exclusive data and statistics outlining the anticipated growth trajectory of the global compounding pharmacies market from 2025 to 2032.

Key Insights:

  • Compounding Pharmacies Market Size (2025E):USD 11.4 Billion
  • Projected Market Value (2032F): USD 16.3 Billion
  • Global Market Growth Rate (CAGR 2025 to 2032): 5.2%

Compounding Pharmacies Market - Report Scope:

Compounding pharmacies specialize in creating customized medications tailored to the specific needs of patients, offering solutions for individuals who require alternative dosage forms, allergen-free medications, or drug combinations not commercially available. These pharmacies cater to hospitals, specialty clinics, long-term care facilities, and individual patients, providing compounded formulations such as topical creams, injectables, oral liquids, and pediatric dosages. Market growth is driven by the rising demand for personalized medicine, increasing drug shortages, and the growing prevalence of chronic diseases requiring specialized treatments.

Market Growth Drivers:

The global compounding pharmacies market is propelled by several key factors, including the rising preference for personalized medicine to address unique patient needs. The increasing incidence of chronic illnesses, such as cancer, cardiovascular diseases, and hormonal imbalances, has heightened demand for customized medications. Additionally, the growing geriatric population requires alternative drug formulations suited for ease of administration. Regulatory support for compounding pharmacies and advancements in pharmaceutical compounding techniques, such as sterile compounding and automation in drug formulation, further boost market expansion. The shortage of certain essential drugs has also led to an increased reliance on compounded medications, particularly in hospital and specialty care settings.

Market Restraints:

Despite promising growth prospects, the compounding pharmacies market faces challenges related to stringent regulatory requirements, concerns over product quality and safety, and high operational costs. Regulatory agencies, such as the U.S. Food and Drug Administration (FDA) and European Medicines Agency (EMA), impose strict guidelines on compounding practices to ensure patient safety. Compliance with these regulations increases costs for pharmacies, particularly for small-scale operators. Additionally, the risk of contamination and variability in drug potency can affect consumer trust and regulatory approvals. The increasing availability of generic and specialty drugs in the commercial market also poses a challenge to the demand for compounded medications.

Market Opportunities:

The compounding pharmacies market presents significant growth opportunities driven by increasing healthcare expenditure, technological advancements in drug compounding, and growing awareness about customized medications. The expansion of home healthcare services and telemedicine platforms allows patients to access compounded medications conveniently. Moreover, innovations in compounding techniques, including 3D drug printing, nanotechnology-based formulations, and the integration of artificial intelligence in medication customization, open new avenues for market players. Strategic partnerships between compounding pharmacies and healthcare providers, along with investments in R&D, will be crucial in capitalizing on emerging opportunities and sustaining market leadership in this evolving industry.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the compounding pharmacies market globally?
  • Which compounding formulations and applications are witnessing increased demand across different healthcare settings?
  • How are regulatory policies shaping the competitive landscape of the compounding pharmacies market?
  • Who are the key players contributing to the compounding pharmacies market, and what strategies are they employing to maintain market relevance?
  • What are the emerging trends and future prospects in the global compounding pharmacies market?

Competitive Intelligence and Business Strategy:

Leading players in the global compounding pharmacies market, including B. Braun Medical Inc., Fagron, Inc., and PharMEDium Services LLC, focus on innovation, quality assurance, and regulatory compliance to gain a competitive edge. These companies invest in R&D to develop advanced compounding solutions, including sterile injectables, hormone replacement therapies, and veterinary compounded medications. Collaborations with hospitals, specialty clinics, and regulatory agencies facilitate market access and ensure adherence to stringent pharmaceutical standards. Additionally, emphasis on automation in compounding processes, training for pharmacists, and consumer education fosters market growth and enhances patient confidence in customized medications.

Key Companies Profiled:

  • B. Braun Medical Inc.
  • Fagron, Inc.
  • PharMEDium Services LLC
  • Pencol Compounding Pharmacy
  • Wedgewood Pharmacy
  • Specialty Compounding LLC
  • Bellevue Pharmacy
  • McGuff Compounding Pharmacy Services, Inc.
  • Rx3 Compounding Pharmacy
  • MEDISCA

Key Segments Covered in Compounding Pharmacies Industry Research

Product:

  • Oral Medication
  • Topical Medications
  • Mouthwashes
  • Suppositories

Application:

  • Medication for Adults
  • Medication for Veterinary
  • Medication for Children
  • Medication for Geriatric

Therapeutic Area:

  • Pain Management
  • Hormone Replacement Therapy

Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East & Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Market Outlook
  • 1.2. Demand Side Trends
  • 1.3. Supply Side Trends
  • 1.4. Analysis and Recommendations

2. Market Overview

  • 2.1. Market Coverage / Taxonomy
  • 2.2. Market Definition / Scope / Limitations
  • 2.3. Inclusion and Exclusions

3. Key Market Trends

  • 3.1. Key Trends Impacting the Market
  • 3.2. Product Innovation / Development Trends

4. Key Success Factors

  • 4.1. Product Adoption Analysis
  • 4.2. Recent Product Approvals/ Launches
  • 4.3. Key Promotional Strategies, By Manufacturers
  • 4.4. Supply Chain Analysis
  • 4.5. Porter's Five Forces Analysis
  • 4.6. PESTEL Analysis
  • 4.7. Regulatory Dynamics

5. Market Background

  • 5.1. Macro-Economic Factors
    • 5.1.1. Global GDP Growth Outlook
    • 5.1.2. Global Healthcare Expenditure Overview
    • 5.1.3. Global Personalized Medicine Market Outlook
  • 5.2. Forecast Factors - Relevance & Impact
    • 5.2.1. Rising geriatric population
    • 5.2.2. Increasing oral medications
    • 5.2.3. Growing public adoption of hormone replacement therapy (HRTs)
    • 5.2.4. Increasing medicine scarcity
    • 5.2.5. Rising pharmaceutical R&D
    • 5.2.6. Rise in pet adoption
    • 5.2.7. Strategic collaborations
  • 5.3. Market Dynamics
    • 5.3.1. Drivers
    • 5.3.2. Restraints
    • 5.3.3. Opportunity Analysis

6. COVID-19 Crisis Analysis

  • 6.1. COVID-19 and Impact Analysis
    • 6.1.1. Revenue By Product
    • 6.1.2. Revenue By Application
    • 6.1.3. Revenue By Therapeutic Area
    • 6.1.4. Revenue By Country
  • 6.2. 2022 Market Scenario

7. Global Compounding Pharmacies Market Demand (Size in US$ Bn) Analysis, 2019 - 2032

  • 7.1. Historical Market Value (US$ Bn) Analysis, 2019 - 2024
  • 7.2. Current and Future Market Value (US$ Bn) Projections, 2025 - 2032
    • 7.2.1. Y-o-Y Growth Trend Analysis
    • 7.2.2. Absolute $ Opportunity Analysis

8. Global Compounding Pharmacies Market Analysis 2019 - 2032, By Product

  • 8.1. Introduction / Key Findings
  • 8.2. Historical Market Size (In Value or Size in US$ Bn) Trend By Product, 2019 - 2024
  • 8.3. Current and Future Market Size (In Value or Size in US$ Bn) Analysis and Forecast By Product, 2025 - 2032
    • 8.3.1. Oral Medications
      • 8.3.1.1. Capsules
      • 8.3.1.2. Tablets
      • 8.3.1.3. Mixtures
      • 8.3.1.4. Lollipops
      • 8.3.1.5. Lozenges
    • 8.3.2. Topical Medications
      • 8.3.2.1. Gels
      • 8.3.2.2. Ointments
      • 8.3.2.3. Creams
      • 8.3.2.4. Lotions
    • 8.3.3. Mouthwashes
    • 8.3.4. Suppositories
  • 8.4. Market Attractiveness Analysis By Product

9. Global Compounding Pharmacies Market Analysis 2019 - 2032, By Application

  • 9.1. Introduction / Key Findings
  • 9.2. Historical Market Size (In Value or Size in US$ Bn) Trend By Application, 2019 - 2024
  • 9.3. Current and Future Market Size (In Value or Size in US$ Bn) Analysis and Forecast By Application, 2025 - 2032
    • 9.3.1. Medication for Adults
    • 9.3.2. Medication for Veterinary
    • 9.3.3. Medication for Children
    • 9.3.4. Medication for Geriatric
  • 9.4. Market Attractiveness Analysis By Application

10. Global Compounding Pharmacies Market Analysis 2019 - 2032, By Therapeutic Area

  • 10.1. Introduction / Key Findings
  • 10.2. Historical Market Size (In Value or Size in US$ Bn) Trend By Therapeutic Area, 2019 - 2024
  • 10.3. Current and Future Market Size (In Value or Size in US$ Bn) Analysis and Forecast By Therapeutic Area, 2025 - 2032
    • 10.3.1. Pain Management
    • 10.3.2. Hormone Replacement Therapy
  • 10.4. Market Attractiveness Analysis By Therapeutic Area

11. Global Compounding Pharmacies Market Analysis 2019 - 2032, by Region

  • 11.1. Introduction
  • 11.2. Historical Market Size (In Value or Size in US$ Bn) Analysis By Region, 2019 - 2024
  • 11.3. Current Market Size (In Value or Size in US$ Bn) Analysis and Forecast By Region, 2025 - 2032
    • 11.3.1. North America
    • 11.3.2. Latin America
    • 11.3.3. Europe
    • 11.3.4. South Asia
    • 11.3.5. East Asia
    • 11.3.6. Oceania
    • 11.3.7. Middle East and Africa (MEA)
  • 11.4. Market Attractiveness Analysis By Region

12. North America Compounding Pharmacies Market Analysis 2019 - 2032

  • 12.1. Introduction
  • 12.2. Historical Market Size (In Value or Size in US$ Bn) Trend Analysis By Market Taxonomy, 2019 - 2024
  • 12.3. Current and Future Market Size (In Value or Size in US$ Bn) Analysis and Forecast By Market Taxonomy, 2025 - 2032
    • 12.3.1. By Country
      • 12.3.1.1. U.S.
      • 12.3.1.2. Canada
    • 12.3.2. By Product
    • 12.3.3. By Application
    • 12.3.4. By Therapeutic Area
  • 12.4. Market Attractiveness Analysis
    • 12.4.1. By Country
    • 12.4.2. By Product
    • 12.4.3. By Application
    • 12.4.4. By Therapeutic Area
  • 12.5. Market Trends
  • 12.6. Key Market Participants - Intensity Mapping
  • 12.7. Drivers and Restraints - Impact Analysis
  • 12.8. Country Level Analysis & Forecast
    • 12.8.1. U.S. Compounding Pharmacies Market Analysis
      • 12.8.1.1. Introduction
      • 12.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 12.8.1.2.1. By Product
        • 12.8.1.2.2. By Application
        • 12.8.1.2.3. By Therapeutic Area
    • 12.8.2. Canada Compounding Pharmacies Market Analysis
      • 12.8.2.1. Introduction
      • 12.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 12.8.2.2.1. By Product
        • 12.8.2.2.2. By Application
        • 12.8.2.2.3. By Therapeutic Area

13. Latin America Compounding Pharmacies Market 2019 - 2032

  • 13.1. Introduction
  • 13.2. Historical Market Size (In Value or Size in US$ Bn) Trend Analysis By Market Taxonomy, 2019 - 2024
  • 13.3. Current and Future Market Size (In Value or Size in US$ Bn) Analysis and Forecast By Market Taxonomy, 2025 - 2032
    • 13.3.1. By Country
      • 13.3.1.1. Brazil
      • 13.3.1.2. Mexico
      • 13.3.1.3. Argentina
      • 13.3.1.4. Rest of Latin America
    • 13.3.2. By Product
    • 13.3.3. By Application
    • 13.3.4. By Therapeutic Area
  • 13.4. Market Attractiveness Analysis
    • 13.4.1. By Country
    • 13.4.2. By Product
    • 13.4.3. By Application
    • 13.4.4. By Therapeutic Area
  • 13.5. Market Trends
  • 13.6. Key Market Participants - Intensity Mapping
  • 13.7. Drivers and Restraints - Impact Analysis
  • 13.8. Country Level Analysis & Forecast
    • 13.8.1. Brazil Compounding Pharmacies Market Analysis
      • 13.8.1.1. Introduction
      • 13.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 13.8.1.2.1. By Product
        • 13.8.1.2.2. By Application
        • 13.8.1.2.3. By Therapeutic Area
    • 13.8.2. Mexico Compounding Pharmacies Market Analysis
      • 13.8.2.1. Introduction
      • 13.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 13.8.2.2.1. By Product
        • 13.8.2.2.2. By Application
        • 13.8.2.2.3. By Therapeutic Area
    • 13.8.3. Argentina Compounding Pharmacies Market Analysis
      • 13.8.3.1. Introduction
      • 13.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 13.8.3.2.1. By Product
        • 13.8.3.2.2. By Application
        • 13.8.3.2.3. By Therapeutic Area

14. Europe Compounding Pharmacies Market Analysis, 2019 - 2032

  • 14.1. Introduction
  • 14.2. Historical Market Size (In Value or Size in US$ Bn) Trend Analysis By Market Taxonomy, 2019 - 2024
  • 14.3. Current and Future Market Size (In Value or Size in US$ Bn) Analysis and Forecast By Market Taxonomy, 2025 - 2032
    • 14.3.1. By Country
      • 14.3.1.1. Germany
      • 14.3.1.2. UK
      • 14.3.1.3. France
      • 14.3.1.4. Italy
      • 14.3.1.5. Russia
      • 14.3.1.6. Spain
      • 14.3.1.7. BENELUX
      • 14.3.1.8. Rest of Europe
    • 14.3.2. By Product
    • 14.3.3. By Application
    • 14.3.4. By Therapeutic Area
  • 14.4. Market Attractiveness Analysis
    • 14.4.1. By Country
    • 14.4.2. By Product
    • 14.4.3. By Application
    • 14.4.4. By Therapeutic Area
  • 14.5. Market Trends
  • 14.6. Key Market Participants - Intensity Mapping
  • 14.7. Drivers and Restraints - Impact Analysis
  • 14.8. Country Level Analysis & Forecast
    • 14.8.1. Germany Compounding Pharmacies Market Analysis
      • 14.8.1.1. Introduction
      • 14.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 14.8.1.2.1. By Product
        • 14.8.1.2.2. By Application
        • 14.8.1.2.3. By Therapeutic Area
    • 14.8.2. UK Compounding Pharmacies Market Analysis
      • 14.8.2.1. Introduction
      • 14.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 14.8.2.2.1. By Product
        • 14.8.2.2.2. By Application
        • 14.8.2.2.3. By Therapeutic Area
    • 14.8.3. Russia Compounding Pharmacies Market Analysis
      • 14.8.3.1. Introduction
      • 14.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 14.8.3.2.1. By Product
        • 14.8.3.2.2. By Application
        • 14.8.3.2.3. By Therapeutic Area
    • 14.8.4. Spain Compounding Pharmacies Market Analysis
      • 14.8.4.1. Introduction
      • 14.8.4.2. Market Analysis and Forecast by Market Taxonomy
        • 14.8.4.2.1. By Product
        • 14.8.4.2.2. By Application
        • 14.8.4.2.3. By Therapeutic Area
    • 14.8.5. France Compounding Pharmacies Market Analysis
      • 14.8.5.1. Introduction
      • 14.8.5.2. Market Analysis and Forecast by Market Taxonomy
        • 14.8.5.2.1. By Product
        • 14.8.5.2.2. By Application
        • 14.8.5.2.3. By Therapeutic Area
    • 14.8.6. Italy Compounding Pharmacies Market Analysis
      • 14.8.6.1. Introduction
      • 14.8.6.2. Market Analysis and Forecast by Market Taxonomy
        • 14.8.6.2.1. By Product
        • 14.8.6.2.2. By Application
        • 14.8.6.2.3. By Therapeutic Area
    • 14.8.7. BENELUX Compounding Pharmacies Market Analysis
      • 14.8.7.1. Introduction
      • 14.8.7.2. Market Analysis and Forecast by Market Taxonomy
        • 14.8.7.2.1. By Product
        • 14.8.7.2.2. By Application
        • 14.8.7.2.3. By Therapeutic Area

15. South Asia Compounding Pharmacies Market Analysis, 2019 - 2032

  • 15.1. Introduction
  • 15.2. Historical Market Size (In Value or Size in US$ Bn) Trend Analysis By Market Taxonomy, 2019 - 2024
  • 15.3. Current and Future Market Size (In Value or Size in US$ Bn) Analysis and Forecast By Market Taxonomy, 2025 - 2032
    • 15.3.1. By Country
      • 15.3.1.1. India
      • 15.3.1.2. Indonesia
      • 15.3.1.3. Malaysia
      • 15.3.1.4. Thailand
      • 15.3.1.5. Rest of South Asia
    • 15.3.2. By Product
    • 15.3.3. By Application
    • 15.3.4. By Therapeutic Area
  • 15.4. Market Attractiveness Analysis
    • 15.4.1. By Country
    • 15.4.2. By Product
    • 15.4.3. By Application
    • 15.4.4. By Therapeutic Area
  • 15.5. Market Trends
  • 15.6. Key Market Participants - Intensity Mapping
  • 15.7. Drivers and Restraints - Impact Analysis
  • 15.8. Country Level Analysis & Forecast
    • 15.8.1. India Compounding Pharmacies Market Analysis
      • 15.8.1.1. Introduction
      • 15.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 15.8.1.2.1. By Product
        • 15.8.1.2.2. By Application
        • 15.8.1.2.3. By Therapeutic Area
    • 15.8.2. Indonesia Compounding Pharmacies Market Analysis
      • 15.8.2.1. Introduction
      • 15.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 15.8.2.2.1. By Product
        • 15.8.2.2.2. By Application
        • 15.8.2.2.3. By Therapeutic Area
    • 15.8.3. Malaysia Compounding Pharmacies Market Analysis
      • 15.8.3.1. Introduction
      • 15.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 15.8.3.2.1. By Product
        • 15.8.3.2.2. By Application
        • 15.8.3.2.3. By Therapeutic Area
    • 15.8.4. Thailand Compounding Pharmacies Market Analysis
      • 15.8.4.1. Introduction
      • 15.8.4.2. Market Analysis and Forecast by Market Taxonomy
        • 15.8.4.2.1. By Product
        • 15.8.4.2.2. By Application
        • 15.8.4.2.3. By Therapeutic Area

16. East Asia Compounding Pharmacies Market Analysis, 2019 - 2032

  • 16.1. Introduction
  • 16.2. Historical Market Size (In Value or Size in US$ Bn) Trend Analysis By Market Taxonomy, 2019 - 2024
  • 16.3. Current and Future Market Size (In Value or Size in US$ Bn) Analysis and Forecast By Market Taxonomy, 2025 - 2032
    • 16.3.1. By Country
      • 16.3.1.1. China
      • 16.3.1.2. Japan
      • 16.3.1.3. South Korea
    • 16.3.2. By Product
    • 16.3.3. By Application
    • 16.3.4. By Therapeutic Area
  • 16.4. Market Attractiveness Analysis
    • 16.4.1. By Country
    • 16.4.2. By Product
    • 16.4.3. By Application
    • 16.4.4. By Therapeutic Area
  • 16.5. Market Trends
  • 16.6. Key Market Participants - Intensity Mapping
  • 16.7. Drivers and Restraints - Impact Analysis
  • 16.8. Country Level Analysis & Forecast
    • 16.8.1. China Compounding Pharmacies Market Analysis
      • 16.8.1.1. Introduction
      • 16.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 16.8.1.2.1. By Product
        • 16.8.1.2.2. By Application
        • 16.8.1.2.3. By Therapeutic Area
    • 16.8.2. Japan Compounding Pharmacies Market Analysis
      • 16.8.2.1. Introduction
      • 16.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 16.8.2.2.1. By Product
        • 16.8.2.2.2. By Application
        • 16.8.2.2.3. By Therapeutic Area
    • 16.8.3. South Korea Compounding Pharmacies Market Analysis
      • 16.8.3.1. Introduction
      • 16.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 16.8.3.2.1. By Product
        • 16.8.3.2.2. By Application
        • 16.8.3.2.3. By Therapeutic Area

17. Oceania Compounding Pharmacies Market Analysis, 2019 - 2032

  • 17.1. Introduction
  • 17.2. Historical Market Size (In Value or Size in US$ Bn) Trend Analysis By Market Taxonomy, 2019 - 2024
  • 17.3. Current and Future Market Size (In Value or Size in US$ Bn) Analysis and Forecast By Market Taxonomy, 2025 - 2032
    • 17.3.1. By Country
      • 17.3.1.1. Australia
      • 17.3.1.2. New Zealand
    • 17.3.2. By Product
    • 17.3.3. By Application
    • 17.3.4. By Therapeutic Area
  • 17.4. Market Attractiveness Analysis
    • 17.4.1. By Country
    • 17.4.2. By Product
    • 17.4.3. By Application
    • 17.4.4. By Therapeutic Area
  • 17.5. Market Trends
  • 17.6. Key Market Participants - Intensity Mapping
  • 17.7. Drivers and Restraints - Impact Analysis
  • 17.8. Country Level Analysis & Forecast
    • 17.8.1. Australia Compounding Pharmacies Market Analysis
      • 17.8.1.1. Introduction
      • 17.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 17.8.1.2.1. By Product
        • 17.8.1.2.2. By Application
        • 17.8.1.2.3. By Therapeutic Area
    • 17.8.2. New Zealand Compounding Pharmacies Market Analysis
      • 17.8.2.1. Introduction
      • 17.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 17.8.2.2.1. By Product
        • 17.8.2.2.2. By Application
        • 17.8.2.2.3. By Therapeutic Area

18. Middle East & Africa (MEA) Compounding Pharmacies Market Analysis, 2019 - 2032

  • 18.1. Introduction
  • 18.2. Historical Market Size (In Value or Size in US$ Bn) Trend Analysis By Market Taxonomy, 2019 - 2024
  • 18.3. Current and Future Market Size (In Value or Size in US$ Bn) Analysis and Forecast By Market Taxonomy, 2025 - 2032
    • 18.3.1. By Country
      • 18.3.1.1. GCC Countries
      • 18.3.1.2. Turkey
      • 18.3.1.3. South Africa
      • 18.3.1.4. North Africa
      • 18.3.1.5. Rest of MEA
    • 18.3.2. By Product
    • 18.3.3. By Application
    • 18.3.4. By Therapeutic Area
  • 18.4. Market Attractiveness Analysis
    • 18.4.1. By Country
    • 18.4.2. By Product
    • 18.4.3. By Application
    • 18.4.4. By Therapeutic Area
  • 18.5. Market Trends
  • 18.6. Key Market Participants - Intensity Mapping
  • 18.7. Drivers and Restraints - Impact Analysis
  • 18.8. Country Level Analysis & Forecast
    • 18.8.1. GCC Countries Compounding Pharmacies Market Analysis
      • 18.8.1.1. Introduction
      • 18.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 18.8.1.2.1. By Product
        • 18.8.1.2.2. By Application
        • 18.8.1.2.3. By Therapeutic Area
    • 18.8.2. Turkey Compounding Pharmacies Market Analysis
      • 18.8.2.1. Introduction
      • 18.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 18.8.2.2.1. By Product/p>
        • 18.8.2.2.2. By Application
        • 18.8.2.2.3. By Therapeutic Area
    • 18.8.3. South Africa Compounding Pharmacies Market Analysis
      • 18.8.3.1. Introduction
      • 18.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 18.8.3.2.1. By Product
        • 18.8.3.2.2. By Application
        • 18.8.3.2.3. By Therapeutic Area
    • 18.8.4. North Africa Compounding Pharmacies Market Analysis
      • 18.8.4.1. Introduction
      • 18.8.4.2. Market Analysis and Forecast by Market Taxonomy
        • 18.8.4.2.1. By Product
        • 18.8.4.2.2. By Application
        • 18.8.4.2.3. By Therapeutic Area

19. Market Structure Analysis

  • 19.1. Market Analysis by Tier of Companies
  • 19.2. Market Concentration
  • 19.3. Market Share Analysis of Top Players
  • 19.4. Market Presence Analysis
    • 19.4.1. Regional footprint of Players
    • 19.4.2. Product foot print by Players
    • 19.4.3. Channel Foot Print by Players

20. Competition Analysis

  • 20.1. Competition Dashboard
  • 20.2. Competition Deep Dive
    • 20.2.1. Fagron
      • 20.2.1.1. Overview
      • 20.2.1.2. Product Portfolio
      • 20.2.1.3. Key Financials
      • 20.2.1.4. Sales Footprint
      • 20.2.1.5. SWOT Analysis
      • 20.2.1.6. Strategy Overview
        • 20.2.1.6.1. Marketing Strategy
        • 20.2.1.6.2. Product Strategy
        • 20.2.1.6.3. Channel Strategy
    • 20.2.2. Fresenius Kabi AG
      • 20.2.2.1. Overview
      • 20.2.2.2. Product Portfolio
      • 20.2.2.3. Key Financials
      • 20.2.2.4. Sales Footprint
      • 20.2.2.5. SWOT Analysis
      • 20.2.2.6. Strategy Overview
        • 20.2.2.6.1. Marketing Strategy
        • 20.2.2.6.2. Product Strategy
        • 20.2.2.6.3. Channel Strategy
    • 20.2.3. PharMEDium Services, LLC,
      • 20.2.3.1. Overview
      • 20.2.3.2. Product Portfolio
      • 20.2.3.3. Key Financials
      • 20.2.3.4. Sales Footprint
      • 20.2.3.5. SWOT Analysis
      • 20.2.3.6. Strategy Overview
        • 20.2.3.6.1. Marketing Strategy
        • 20.2.3.6.2. Product Strategy
        • 20.2.3.6.3. Channel Strategy
    • 20.2.4. Institutional Pharmacy Solutions
      • 20.2.4.1. Overview
      • 20.2.4.2. Product Portfolio
      • 20.2.4.3. Key Financials
      • 20.2.4.4. Sales Footprint
      • 20.2.4.5. SWOT Analysis
      • 20.2.4.6. Strategy Overview
        • 20.2.4.6.1. Marketing Strategy
        • 20.2.4.6.2. Product Strategy
        • 20.2.4.6.3. Channel Strategy
    • 20.2.5. Cantrell Drug Company
      • 20.2.5.1. Overview
      • 20.2.5.2. Product Portfolio
      • 20.2.5.3. Key Financials
      • 20.2.5.4. Sales Footprint
      • 20.2.5.5. SWOT Analysis
      • 20.2.5.6. Strategy Overview
        • 20.2.5.6.1. Marketing Strategy
        • 20.2.5.6.2. Product Strategy
        • 20.2.5.6.3. Channel Strategy
    • 20.2.6. Lorraine's Pharmacy
      • 20.2.6.1. Overview
      • 20.2.6.2. Product Portfolio
      • 20.2.6.3. Key Financials
      • 20.2.6.4. Sales Footprint
      • 20.2.6.5. SWOT Analysis
      • 20.2.6.6. Strategy Overview
        • 20.2.6.6.1. Marketing Strategy
        • 20.2.6.6.2. Product Strategy
        • 20.2.6.6.3. Channel Strategy
    • 20.2.7. B. Braun Melsungen AG Company
      • 20.2.7.1. Overview
      • 20.2.7.2. Product Portfolio
      • 20.2.7.3. Key Financials
      • 20.2.7.4. Sales Footprint
      • 20.2.7.5. SWOT Analysis
      • 20.2.7.6. Strategy Overview
        • 20.2.7.6.1. Marketing Strategy
        • 20.2.7.6.2. Product Strategy
        • 20.2.7.6.3. Channel Strategy

21. Assumptions and Acronyms Used

22. Research Methodology